Author

Shirley Bierkatz

City Of Hope National Medical Center

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Assay:flow cytometry· 1 Organism:human· 1 Assay:metabolomics· 1 Approach:statistical model· 1

Frequent Co-Authors

Bryan Garcia· 1 shared Dasol Wi· 1 shared Dat NgoiD· 1 shared Eric R. HaasiD· 1 shared Erin TanakaiD· 1 shared Ibrahim Taha AldossiD· 1 shared James Lester FigarolaiD· 1 shared Jamie R. WagneriD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Bryan Garcia

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Immunometabolic determinants of long-term response in leukemia patients receiving CD19 CAR T cell therapy

Lior Goldberg, Eric R. Haas, Jiaqi Wu, Bryan Garcia, Ryan Z. Urak, Vibhuti Vyas, Ruby Espinosa, Tamara Munoz, Shirley Bierkatz, Khyatiben V. Pathak, Nathaniel P. Hansen, Patrick Pirrotte, Jyotsana Singhal, James Lester Figarola, Ricardo Zerda Noriega, , Xiuli Wang

This study identifies immunometabolic factors in CD19 CAR T cells that predict long-term response in B-ALL patients and suggests mTOR inhibition as a strategy to enhance anti-tumor activity.

Nature Communications · Feb 20, 2026Peer-reviewedImmunology